High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome

Nephrology Dialysis Transplantation

Volumn 24, Issue 6, 2009, Pages 1870-1875

  Escher, Genevive ^a   Cristiano, Martino ^a   Causevic, Maja ^a   Baumann, Marc ^a   Frey, Felix J ^a   Surbek, Daniel ^a   Mohaupt, Markus G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Aldosterone; Aldosterone synthase; Arterial hypertension; Pre eclampsia; Pregnancy outcome

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; LABETALOL; METHYLDOPA; MINERALOCORTICOID RECEPTOR; NIFEDIPINE; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INTRON; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SITE DIRECTED MUTAGENESIS; URINALYSIS; URINE LEVEL; WILD TYPE;

ADULT; ALDOSTERONE; ALDOSTERONE SYNTHASE; BASE SEQUENCE; BLOOD PRESSURE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INFANT, NEWBORN; MUTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, MINERALOCORTICOID; RENIN;

EID: 67651091681     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn763     Document Type: Article

References (36)

1. Broughton-Pipkin F. Risk factors for preeclampsia. NEnglJMed 2001; 344: 925-926
2. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357: 2002-2006
3. Irgens HU, Reisaeter L, Irgens LM et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213-1217
4. Bauknecht H, Vecsei P, Endres H et al. Urinary free 18-hydroxycorticosterone, plasma aldosterone, and urinary aldosterone metabolites in normal pregnancy. Am J Obstet Gynecol 1982; 144: 28-34
5. Brown MA, Sinosich MJ, Saunders DM et al. Potassium regulation and progesterone-aldosterone interrelationships in human pregnancy: a prospective study. Am J Obstet Gynecol 1986; 155: 349-353
6. Wacker J, Piel P, Lewicka S et al. Increased aldosterone-18- glucuronide/tetrahydroaldosterone ratios in pregnancy. Endocr Res 1995; 21: 197-202
7. McCance DR, McKnight JA, Traub AI et al. Plasma atrial natriuretic factor levels during normal pregnancy and pregnancy complicated by diabetes mellitus and hypertension. J Hum Hypertens 1990; 4: 31-35
8. Gallery ED, Brown MA. Control of sodium excretion in human pregnancy. Am J Kidney Dis 1987; 9: 290-295
9. Mulrow PJ, Schneider G. Aldosterone regulation in the maternal and fetal rat in pregnancy. Perspect Nephrol Hypertens 1976; 5: 229-237
10. Nolten WE, Lindheimer MD, Oparil S et al. Desoxycorticosterone in normal pregnancy: I. Sequential studies of the secretory patterns of desoxycorticosterone, aldosterone, and cortisol. Am J Obstet Gynecol 1978; 132: 414-420
11. Shojaati K, Causevic M, Kadereit B et al. Evidence for compro-mised aldosterone synthase enzyme activity in preeclampsia. Kidney Int 2004; 66: 2322-2328
12. Nicod J, Bruhin D, Auer L et al. A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 2003; 88: 2495-2500
13. Geller DS, Rodriguez-Soriano J, Vallo Boado A et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 1998; 19: 279-281
14. Higgins JR, de Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet 2001; 357: 131-135
15. Shackleton CH. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 1993; 45: 127-140
16. Davies E, Holloway CD, Ingram MC et al. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) 2001; 54: 813-817
17. Geller DS, Farhi A, Pinkerton N et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289: 119-123
18. Smolenicka Z, Bach E, Schaer A et al. A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab 1998; 83: 1814-1817
19. Abdelhamid S, Blomer R, Hommel G et al. Urinary tetrahydroaldos-terone as a screening method for primary aldosteronism: a comparative study. Am J Hypertens 2003; 16: 522-530
20. Luft FC. Molecular genetics of human hypertension. Curr Opin Nephrol Hypertens 2000; 9: 259-266
21. Curnow KM, Pham T, August P. The L10F mutation of angiotensinogen is rare in pre-eclampsia. J Hypertens 2000; 18: 173-178
22. Arngrimsson R, Purandare S, Connor M et al. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet 1993; 4: 114-115
23. Harrison GA, Humphrey KE, Jones N et al. A genomewide link-age study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 1997; 60: 1158-1167
24. Pridjian G, Puschett JB. Preeclampsia: Part 1. Clinical and pathophysiologic considerations. Obstet Gynecol Surv 2002; 57: 598-618
25. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-6
26. Lindheimer MD, Katz AI. Renal physiology and disease in pregnancy. In: Seldin DW, Giebisch G (eds). The Kidney: Physiology and Patho-physiology, 2nd edn. New York: Raven Press, 1992, 3371-3433.
27. Percin FE, Cetin M, Pinarbasi E et al. Lack of association between the CYP11B2 gene polymorphism and preeclampsia, eclampsia, and the HELLP syndrome in Turkish women. Eur J Obstet Gynecol Reprod Biol 2006; 127: 213-217
28. Nilsson E, Salonen Ros H, Cnattingius S, Lichtenstein P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG 2004; 111: 200-206
29. Salonen Ros H, Lichtenstein P, Lipworth L et al. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000; 91: 256-260
30. Thornton JG, Macdonald AM. Twin mothers, pregnancy hypertension and pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 570-575
31. Lim PO, Macdonald TM, Holloway C et al. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 2002; 87: 4398-4402
32. Raff H, Kohandarvish S. The effect of oxygen on aldosterone release from bovine adrenocortical cells in vitro: PO2 versus steroidogenesis. Endocrinology 1990; 127: 682-687
33. Lawrence DL, Skatrud JB, Shenker Y. Effect of hypoxia on atrial natriuretic factor and aldosterone regulation in humans. Am J Physiol 1990; 258: E243-E248
34. Pearce D, Bhargava A, Cole TJ. Aldosterone: its receptor, target genes, and actions. Vitam Horm 2003; 66: 29-76
35. Schmider-Ross A, Wirsing M, Buscher U et al. Analysis of the S810L point mutation of the mineralocorticoid receptor in patients with pregnancy-induced hypertension. Hypertens Pregnancy 2004; 23: 113-119
36. Tempfer CB, Jirecek S, Riener EK et al. Polymorphisms of throm-bophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig 2004; 11: 227-231